Skip to content

Multimodal Imaging Analysis, SD-OCT and OCT Angiography, Retinal Variations Observed in Dialysis Patients

Multimodal Imaging Analysis, SD-OCT and OCT Angiography, Retinal Variations Observed in Dialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03804216
Acronym
OCTADIAL
Enrollment
20
Registered
2019-01-15
Start date
2019-01-01
Completion date
2020-06-01
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure

Brief summary

Little knowledge exist on the short and long-term ophthalmological effect of the dialysis. Some studies stated a variation of the thickness subfoveal choroidal before and after a session of dialyse as well as variations of the coat of optical fibers measured in OCT. The Optical Coherence Tomography angiography OCT is a not invasive imaging technique which is now a part of examinations of investigation in imaging of retina. This technique allows to study the retinal macula vascularization without injection of contrast agent and thus allows to deepen the knowledge in medical domains where the exploration was to limited because of the invasive character of the examinations. The hypothesis of this project is that hemodynamic change during the hemodialysis may lead fine variations of the retinal vascularization in the short-term (the day of the dialysis) but also in the longer term (over 1 year).

Interventions

OTHERMultimodal Imaging Analysis

The patients are seen in consultation ophthalmological before and the 1 hour after their session of dialysis. THE OCT angiography and other not invasive ophthalmological examinations will be realized during the follow-up

Sponsors

Centre Hospitalier Intercommunal Creteil
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication of treatment by hemodialysis * First session of dialysis * Hemodialysis planned for 1 minimum year

Exclusion criteria

* particular ophthalmological Histories: vitreo-retinal surgery, strong nearsightedness, chronic glaucoma * Unaffiliated in a national insurance scheme

Design outcomes

Primary

MeasureTime frameDescription
vascular density before hemodialysisbefore hemodialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm
vascular density 1 hour after hemodialysis1 hour after hemodialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm

Secondary

MeasureTime frameDescription
vascular density 6 month after dialysis6 month after dialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm
vascular density 12 month after dialysis12 month after dialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm
vascular density before dialysisbefore dialysismesure by OCTA
vascular density 1 hour after dialysis1 hour after dialysismesure by OCTA
size of coat retinal optical fibers before dialysisbefore dialysisvariation of the coat
vascular density 1 month after dialysis1 month after dialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm
size of coat retinal optical fibers 1 month after dialysis1 month after dialysisvariation of the coat
size of coat retinal optical fibers 3 month after dialysis3 month after dialysisvariation of the coat
size of coat retinal optical fibers 6 month after dialysis6 month after dialysisvariation of the coat
size of coat retinal optical fibers 12 month after dialysis12 month after dialysisvariation of the coat
size of coat retinal optical fibers 1 hour after dialysis1 hour after dialysisvariation of the coat
vascular density 3 month after dialysis3 month after dialysisAnalysis of the variation of the vascular densities in retinal macula in the central 6 mm

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026